Hospital Pharmacy, RWTH Aachen University Hospital, Aachen; Department of Clinical Pharmacy, Institute of Pharmacy, University of Bonn, Bonn.
Hospital Pharmacy, RWTH Aachen University Hospital, Aachen.
Pharmazie. 2024 Oct 1;79(9):209-214. doi: 10.1691/ph.2024.4540.
: Of all adverse drug reactions, 35-45% are due to medication errors and would therefore be preventable. Thus, it is essential to implement effective strategies to prevent medication errors. However, it remains unclear whether medication reviews provide an additional benefit compared to medication reconciliation regarding medication safety. : The present study aimed to evaluate whether medication reconciliation and medication reviews affect the incidence of preventable adverse drug reactions in elderly patients. : Non-elective patients 65 years and above admitted to the hospital, taking at least one high-risk drug, were eligible for participation in a three-armed randomized controlled trial. One group went through the medication reconciliation process, a second group received a comprehensive medication review, including medication reconciliation, and the third group did not receive any pharmaceutical intervention (control group). The incidence of preventable adverse drug reactions during hospitalization was set as the primary endpoint. The severity of the preventable adverse drug reactions and the number and clinical relevance of drug-related problems and discrepancies were defined as secondary endpoints. : In 207 patients, 74 preventable adverse drug reactions were detected. Neither medication reconciliation nor medication reviews showed a significant impact on the incidence of preventable adverse drug reactions compared to the control group. However, medication reviews significantly reduced the severity of preventable adverse drug reactions (p=0.017). : The current study results suggest that medication reviews may have an impact on a clinically relevant outcome by reducing the severity of preventable adverse drug reactions. A significant impact of medication reconciliation on clinically relevant outcomes could not be demonstrated. Based on the results of this study, when deciding on a pharmaceutical intervention comprehensive medication reviews should be preferred over sole medication reconciliation whenever possible.
所有药物不良反应中,35-45%是由用药错误导致的,因此是可以预防的。因此,实施有效的策略来预防用药错误至关重要。然而,用药审核是否比用药重整在用药安全性方面更有优势仍不清楚。
本研究旨在评估用药重整和用药审核是否会影响老年患者中可预防的药物不良反应的发生率。
符合条件的患者为非择期入院且年龄 65 岁及以上、服用至少一种高危药物的患者。患者被随机分配到三组:一组接受用药重整,一组接受全面的用药审核(包括用药重整),第三组不接受任何药物干预(对照组)。住院期间可预防的药物不良反应的发生率是主要终点。可预防的药物不良反应的严重程度以及药物相关问题和差异的数量和临床相关性是次要终点。
在 207 名患者中,共发现 74 例可预防的药物不良反应。与对照组相比,用药重整和用药审核均未显著降低可预防的药物不良反应的发生率。然而,用药审核显著降低了可预防的药物不良反应的严重程度(p=0.017)。
本研究结果表明,用药审核可能会通过降低可预防的药物不良反应的严重程度对临床相关结局产生影响。用药重整对临床相关结局的显著影响未能得到证实。基于本研究的结果,在决定药物干预措施时,只要有可能,应优先选择全面的用药审核,而不是仅进行用药重整。